|
CN111808086A
|
|
Heterocyclic substituted styryl-4-phenylpyridine derivative, preparation method and medical application thereof
|
|
WO2020228649A1
|
|
Substituted phenylpropenylpyridine derivative, and preparation method therefor and medical use thereof
|
|
WO2021027304A1
|
|
Analgesic compound, preparation method therefor, and pharmaceutical use thereof
|
|
WO2020192553A1
|
|
Sulfonyl-substituted benzoheterocyclic formamide derivative, and preparation method therefor and medical use thereof
|
|
CA3109765A1
|
|
Btk inhibitor, pharmaceutically acceptable salt, polymorph and application thereof
|
|
CN111662284A
|
|
Biheterocyclic substituted oxaspiro derivative, preparation method and medical application thereof
|
|
WO2020147848A1
|
|
Tricyclic substituted oxaspiro derivative, preparation method therefor, and pharmaceutical use thereof
|
|
WO2020147582A1
|
|
Amide derivative substituted by cycloalkyl, preparation method for amide derivative, and use in medicine
|
|
WO2020199683A1
|
|
Nitrogen heterocycle substituted sulfonylbenzamide derivative, preparation method therefor and use thereof in medicine
|
|
WO2020108579A1
|
|
Amino-substituted pyridone derivative, preparation method therefor, and pharmaceutical use thereof
|
|
CN111727186A
|
|
Biheterocyclic substituted pyridine-2 (1H) -ketone derivative, preparation method and medical application thereof
|
|
CN110256446A
|
|
Cyclopenta [4,5] Pyrrolopyrazine -1- ketone derivatives and its application that benzheterocycle replaces
|
|
CN110105275A
|
|
Amide derivatives, its preparation method and purposes pharmaceutically
|
|
US2021087156A1
|
|
Pharmaceutically acceptable salts of benzodicycloalkane derivative, polymorphic substance thereof, and application thereof
|
|
WO2019206155A1
|
|
Ezh2 inhibitor and pharmaceutically acceptable salts and polymorphic substances thereof, and application of ezh2 inhibitor
|
|
EP3786161A1
|
|
Cdk4/6 inhibitor and pharmaceutically acceptable salt and polymorph thereof and use thereof
|
|
CN109956898A
|
|
Immunomodulator and its preparation method and purposes pharmaceutically
|
|
CN110366553A
|
|
4,6,7- tri- replaces 1,2- pyrrolin simultaneously [3,4-c] pyridine/pyrimidine -3- ketone derivatives and purposes
|
|
WO2019019851A1
|
|
Sodium ion channel inhibitor and pharmaceutically acceptable salt and polymorph thereof and use thereof
|
|
CN109956937A
|
|
N- (2- cyclohexyl-ethyl) carboxamides derivatives, its preparation method and purposes pharmaceutically
|
